L&G Pharma Breakthrough UCITS ETF

ISIN DE000A2H9VJ3

 | 

WKN A2H9VJ

TER
0.49% p.a.
Distribution policy
Accumulating
Replication
Full replication
Fund size
7 m
  • This fund has been liquidated or merged. Consequently, no fund information is updated anymore. For more information about the fund, please contact the fund provider.
 

Overview

Trade this ETF at your broker

Choose your broker
Ad
Broker tip: Trade this ETF for 0.99€ per Order at the Scalable broker or for free in a savings plan. Find out more

Description

The L&G Pharma Breakthrough UCITS ETF seeks to track the Solactive Pharma Breakthrough Value index. The Solactive Pharma Breakthrough Value index tracks companies involved in the development and manufacturing of so-called "orphan drugs". Orphan drugs are drugs that target very rare diseases.
 
The ETF's TER (total expense ratio) amounts to 0.49% p.a.. The L&G Pharma Breakthrough UCITS ETF is the only ETF that tracks the Solactive Pharma Breakthrough Value index. The ETF replicates the performance of the underlying index by full replication (buying all the index constituents). The dividends in the ETF are accumulated and reinvested in the ETF.
 
The L&G Pharma Breakthrough UCITS ETF is a very small ETF with 7m Euro assets under management. The ETF was launched on 15 December 2017 and is domiciled in Ireland.
Show more Show less

Chart

Basics

Data

Fund size
EUR 7 m
Total expense ratio
0.49% p.a.
Replication Physical (Full replication)
Legal structure ETF
Strategy risk Long-only
Fund currency USD
Currency risk Currency unhedged
Volatility 1 year (in EUR)
26.83%
Inception/ Listing Date 15 December 2017
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Fund Provider Legal & General (LGIM)
Tax data Bundesanzeiger
Germany Unknown
Switzerland Unknown
Austria Tax Reporting Fund
UK Unknown
Indextype Total return index
Swap counterparty -
Collateral manager BNY Mellon Fund Services (Ireland) Limited
Securities lending No
Securities lending counterparty

Similar ETFs

This section provides you with information on other ETFs with a similar investment focus to the L&G Pharma Breakthrough UCITS ETF.
Similar ETFs via ETF search
Similar ETFs via investment guides
How do you like our new ETF profile? Here you'll find our Questionnaire.

Performance

Returns overview

YTD +5.23%
1 month +25.81%
3 months -3.88%
6 months +19.14%
1 year +13.93%
3 years -
5 years -
Since inception (MAX) -
2023 +14.77%
2022 -
2021 -
2020 -

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 26.83%
Volatility 3 years -
Volatility 5 years -
Return per risk 1 year 0.52
Return per risk 3 years -
Return per risk 5 years -
Maximum drawdown 1 year -
Maximum drawdown 3 years -
Maximum drawdown 5 years -
Maximum drawdown since inception -

Rolling 1 year volatility

Stock exchange

Listings

Listing Trade Currency Ticker Bloomberg /
iNAV Bloomberg Code
Reuters RIC /
iNAV Reuters
Market Maker
Stuttgart Stock Exchange EUR ETLI -
-
-
-
-
XETRA EUR ETLI
IBIOT

Further information

Further ETFs on the Solactive Pharma Breakthrough Value index

Fund name Fund Size in m € (AuM) TER
in % p.a.
Distribution policy Replication method
L&G Pharma Breakthrough UCITS ETF 21 0.49% p.a. Accumulating Full replication

Frequently asked questions

What is the name of ETLI?

The name of ETLI is L&G Pharma Breakthrough UCITS ETF.

What is the ticker of L&G Pharma Breakthrough UCITS ETF?

The primary ticker of L&G Pharma Breakthrough UCITS ETF is ETLI.

What is the ISIN of L&G Pharma Breakthrough UCITS ETF?

The ISIN of L&G Pharma Breakthrough UCITS ETF is DE000A2H9VJ3.

What are the costs of L&G Pharma Breakthrough UCITS ETF?

The total expense ratio (TER) of L&G Pharma Breakthrough UCITS ETF amounts to 0.49% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is L&G Pharma Breakthrough UCITS ETF paying dividends?

L&G Pharma Breakthrough UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of L&G Pharma Breakthrough UCITS ETF?

The fund size of L&G Pharma Breakthrough UCITS ETF is 7m Euro. See the following article for more information about the size of ETFs.

Track your ETF strategies online

— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.